GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daiichi Sankyo Co Ltd (STU:D4S) » Definitions » Pretax Margin %

Daiichinkyo Co (STU:D4S) Pretax Margin % : 18.45% (As of Sep. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Daiichinkyo Co Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Daiichinkyo Co's Pre-Tax Income for the three months ended in Sep. 2024 was €519 Mil. Daiichinkyo Co's Revenue for the three months ended in Sep. 2024 was €2,814 Mil. Therefore, Daiichinkyo Co's pretax margin for the quarter that ended in Sep. 2024 was 18.45%.

The historical rank and industry rank for Daiichinkyo Co's Pretax Margin % or its related term are showing as below:

STU:D4S' s Pretax Margin % Range Over the Past 10 Years
Min: 7.04   Med: 9.21   Max: 18.64
Current: 18.64


STU:D4S's Pretax Margin % is ranked better than
80% of 995 companies
in the Drug Manufacturers industry
Industry Median: 5.23 vs STU:D4S: 18.64

Daiichinkyo Co Pretax Margin % Historical Data

The historical data trend for Daiichinkyo Co's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daiichinkyo Co Pretax Margin % Chart

Daiichinkyo Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.38 7.70 7.04 9.92 14.81

Daiichinkyo Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.31 21.87 8.73 25.26 18.45

Competitive Comparison of Daiichinkyo Co's Pretax Margin %

For the Drug Manufacturers - General subindustry, Daiichinkyo Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daiichinkyo Co's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daiichinkyo Co's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Daiichinkyo Co's Pretax Margin % falls into.



Daiichinkyo Co Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Daiichinkyo Co's Pretax Margin for the fiscal year that ended in Mar. 2024 is calculated as

Pretax Margin=Pre-Tax Income (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=1456.797/9835.581
=14.81 %

Daiichinkyo Co's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=519.269/2814.495
=18.45 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Daiichinkyo Co  (STU:D4S) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Daiichinkyo Co Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Daiichinkyo Co's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Daiichinkyo Co Business Description

Traded in Other Exchanges
Address
3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, JPN, 103-8426
Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2023, approximately one third of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates, or ADCs. Its three lead ADCs are Enhertu (HER2), Dato-DXd (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu entered the clinic in 2015 and received its first US approval in December 2019 for third-line late-stage HER2-positive breast cancer. It is also approved for HER2-positive stomach cancers and HER2 mutant non-small cell lung cancer.

Daiichinkyo Co Headlines

No Headlines